Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...

A new treatment in which surgeons implant a chip on a critical nerve could mean relief for the eight million people in the UK ...

FDA approves Zepbound for sleep apnoea, a weight-loss medication that improves OSA symptoms in obese patients.

Acurable’s AcuPebble became the first device to receive a CE mark for fully automated obstructive sleep apnoea diagnosis.

The battery-free, single-incision, and leadless system represents a solution for adults suffering from moderate to severe OSA ...

Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood ...

First UK patients describe receiving the technology which could spell the end for the uncomfortable masks some sufferers have ...

The first UK patients have been fitted with the Genio Nyxoah implant, a new treatment for sleep apnoea which stimulates the ...

The technology could spell the end for uncomfortable machinery which some people need to sleep at night. Sleep apnoea causes ...

A grandmother who has suffered from sleep apnoea for a decade has been fitted with a groundbreaking piece of tech to tackle ...

The procedure to fit the Genio Nyxoah implant was carried out at University College London Hospitals NHS Foundation Trust ...

Eight million people in the UK suffer from sleep apnoea. Their airway becomes obstructed, and their breathing repeatedly stops for several seconds or even minutes. But surgeons have now begun ...